filmov
tv
DKD treatment update: SGLT2 inhibitors and finerenone | Ian de Boer & Amrit Lamba
Показать описание
Nephrologist Ian de Boer joins primary care physician Amrit Lamba to discuss how the recent approval of finerenone and extension of the dapagliflozin label is likely to influence the treatment of kidney disease in people with type 2 diabetes.
0:18:00
0:09:06
0:58:13
0:47:18
0:01:13
0:40:23
0:06:11
0:49:14
0:46:01
0:59:34
0:40:42
0:02:26
0:28:56
0:30:05
0:47:06
0:17:36
1:53:40
0:08:24
0:31:30
0:06:46
1:00:33
1:02:19
0:23:00
0:06:58